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Abstract. There is an unmet need for methods to help in the early detection of cervical precancer. Optical spec-
troscopy-based techniques, such as Raman spectroscopy, have shown great potential for diagnosis of different
cancers, including cervical cancer. However, relatively few studies have been carried out on liquid-based cytol-
ogy (LBC) pap test specimens and confounding factors, such as blood contamination, have been identified.
Previous work reported a method to remove blood contamination before Raman spectroscopy by pretreatment
of the slides with hydrogen peroxide. The aim of the present study was to extend this work to excessively bloody
samples to see if these could be rendered suitable for Raman spectroscopy. LBC ThinPrep specimens were
treated by adding hydrogen peroxide directly to the vial before slide preparation. Good quality Raman spectra
were recorded from negative and high grade (HG) cytology samples with no blood contamination and with heavy
blood contamination. Good classification between negative and HG cytology could be achieved for samples with
no blood contamination (sensitivity 92%, specificity 93%) and heavy blood contamination (sensitivity 89%, speci-
ficity 88%) with poorer classification when samples were combined (sensitivity 82%, specificity 87%). This study
demonstrates for the first time the improved potential of Raman spectroscopy for analysis of ThinPrep spec-
imens regardless of blood contamination. © 2018 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO
.23.5.055001]
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1 Introduction
Cervical cancer is the fourth most common cancer in women
worldwide with an estimated 528,000 cases and 266,000 deaths
in 2012.1 The link between cervical cancer and high risk human
papilloma virus (HPV) infection and the molecular control of
the cell cycle is firmly established.2 The presence of an HPV
infection does not automatically mean the development of
cervical cancer or precancer [cervical intraepithelial neoplasia
(CIN)]. However, the HPV virus can integrate its viral DNA
into the host cell’s DNA located in the cell’s nucleus. This inte-
gration disrupts the host cell’s control of cell growth and rep-
lication and can lead to malignant transformation.3 The most
common method for cervical screening is based on the papani-
colaou test (pap test), which is designed to screen for signs of
precancer and cancer of the cervix. The pap test requires cells to
be scraped from the cervix, fixed to a glass slide, stained, and
reviewed by a trained cytologist. Cellular abnormalities are
identified based on cellular morphology and staining character-
istics and classified according to the degree of dysplasia. The
ThinPrep liquid-based cytology (LBC) method involves the
patient’s cells being transferred into a specimen vial containing
PreservCyt transport medium. PreservCyt is an alcohol-based
solution that preserves cell morphology and breaks down
biological components, such as mucin and blood. The normal
smear pattern is made up of epithelial and nonepithelial compo-
nents [Fig. 1(a)]. The epithelial cell components include para-
basal cells, intermediate cells, superficial cells, endocervical
and endometrial cells. Nonepithelial cell components include
red blood cells, lymphocytes, histiocytes, polymorphs, mucus,
and bacteria. Red blood cells are 7 to 8 μm in size and stain
red or pink with the pap stain. They are often found in cervical
samples, either due to menstruation or inflammation and their
presence can also be used as an indicator of disease (precancer).4
A patient’s cervix with a high-grade (HG) lesion will often bleed
on contact with the cervical brush and, as a result, the smear
becomes contaminated with blood. The presence of blood in
the sample will often dilute diagnostic cells, cover and surround
cell groups, increase screening time, and make microscopic
interpretation difficult [Fig. 1(b)]. PreservCyt contains a lysis
agent for mucus and red blood cells but excessive blood in
the sample vial will prevent a satisfactory smear being produced.
High volumes of red blood cells will prevent the collection of
epithelial cells onto the polycarbonate filter membrane during
processing resulting in a ringed halo effect with red blood
cells deposited mostly around the edges of the smear with
very few epithelial cells present [Fig. 1(c)].
Cytology laboratories often annotate pap smears according to
a blood scale index, where 0 indicates no visible evidence of
blood present and 3 indicates an extremely bloody sample
(Fig. 2). Samples presenting as a 2 or 3 on the blood scale are
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often either rejected as being unsatisfactory or treated with a
wash solution to lyse more of the red blood cells to increase
the number of epithelial cells present on the slide. This blood
scale grading is subjective and is only based on a visual appear-
ance of a sample. The advantage of the pap test is that it is a
noninvasive and widely accepted screening-based test. How-
ever, despite a high specificity of 96.5%, a lower sensitivity
of 85% can be due to sampling, technical and interobserver
errors associated with the subjectivity of the test.4 Over the
past 20 years, Raman spectroscopy has shown potential for the
diagnosis of cervical cancer both in vivo and ex vivo.5–12 Raman
spectroscopy is based on inelastic light scattering in which a
sample is illuminated by monochromatic laser light and inter-
actions between the incident photons and molecules in the sam-
ple result in the scattering of the light. The coupling of the light
generates vibrations within the sample, which are characteristic
of the chemical structure. The energy of the scattered light is
reduced by an amount equal to the vibrational energy, which is
called the Raman shift. This means that the position, peaks, and
shape of the Raman bands carry information about the molecu-
lar makeup of the sample. The Raman spectrum of cells and
tissues is made up of contributions frommany biochemical com-
ponents, including DNA, RNA, proteins, lipids, and carbohy-
drates.12 To date, most likely due to confounding factors, such
as blood contamination, there have been relatively few studies
on Raman spectroscopy of cervical smear samples.13–19 Rubina
et al.16 described the influence of blood on the Raman spectra of
cervical cell pellets and how this might lead to false interpreta-
tions. Classification efficiency of 86% and 84% was reported for
normal and abnormal samples, respectively, and this decreased
to 78% and 79% after samples were treated with red blood cell
lysis buffer to reduce blood contamination. A previous study by
our group17 addressed many of the issues involved in recording
Raman spectra from LBC (ThinPrep) samples and described a
method to remove blood contamination before Raman spectros-
copy based on pretreatment of the slides with hydrogen perox-
ide. This was shown to minimize variability and to result in the
collection of highly reproducible data with excellent discrimina-
tion between negative and HG samples. However, only blood
scale 0 and blood scale 1 samples were used for this study
as the treatment was not found to be effective for excessively
contaminated blood scale 2 and 3 samples. Kerr et al.20 inves-
tigated the effect of blood contamination on Raman spectra of
urine cytology samples. They determined that spectra recorded
from samples with a low level of blood appeared free from con-
tamination due to the effective removal of many of the red blood
cells using the lysing agent CytoLyt. However, for excessively
bloody samples, several additional Raman peaks associated with
blood were observed leading to the conclusion that excessively
bloody samples are not suitable for diagnostics with Raman
microspectroscopy. The aim of the present study was to extend
our previous study17 to samples annotated as blood scale 2 and 3
to investigate if these excessively bloody samples could be
treated to render them suitable for Raman spectroscopy.
2 Materials and Methods
2.1 Samples and Blood Treatment
Cervical LBC samples were provided by Coombe Women and
Infants University Hospital, Dublin, Ireland, for spectroscopic
analysis with the final clinical report prepared by the cytologist
and/or pathologist. This study was approved by the Research
Ethics Committee at Coombe Women and Infants University
Hospital. A set of 30 samples were selected, 15 HG intraepithe-
lial neoplasia samples, which received a CIN 2 or CIN 3, result
on their associated biopsy from pathology, and 15 negative sam-
ples (TN), which received a negative result from cytology. All
Fig. 1 (a) Pap smear after staining. Note the presence of intermediate (blue), superficial (pink) cells, and
lymphocytes (indicated by arrows), (b) bloody smear pattern with red blood cells, obscuring diagnostic
cells. Bar ¼ 35 μm. (c) Pap smear contaminated with blood showing ringed halo effect.
Fig. 2 ThinPrep vials graded according to the blood scale index,
where 0 indicates no visible evidence of blood and 3 indicates an
extremely bloody sample.
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cytology samples were evaluated by eye according to the blood
scale index and annotated as being either a grade 0, 1, 2, or 3.
HeLa cervical cancer cells were also prepared and fixed as
for ThinPrep samples in PreservCyt. These samples were seeded
with blood to mimic excessively bloody cytology samples. This
was achieved by adding blood to the samples until they visually
represented a blood scale 2 and 3 index sample.
Each ThinPrep sample vial was mixed for 3 min to break up
cellular clumps. The sample was then poured into a 50-ml cen-
trifuge tube and centrifuged for 5 min at 300 rpm. The super-
natant was removed and 1 ml of H2O2 was added and mixed for
30 s. About 20 ml of PreservCyt was added to neutralize the
H2O2. The sample was then centrifuged for 5 min at 600 rpm.
Most of the supernatant was removed. The cell pellet was
resuspended multiple times with a 1-ml pipette to break up
cell clumps. The 20 ml of PreservCyt was then added and
the contents poured back into the original vial.
2.2 ThinPrep Slide Preparation
The samples were then prepared using the ThinPrep 2000
processor (Hologic Inc., Marlborough, Massachusetts). The
ThinPrep process begins with the patient’s gynecological sam-
ple being collected by the clinician using either a cervical broom
or brush. The brush/broom is then rinsed in the specimen vial
containing PreservCyt transport medium (ThinPrep Pap Test;
Cytyc Corporation, Boxborough, Massachusetts). The ThinPrep
sample vial is then capped, labeled, and sent to the lab to be
processed. The ThinPrep processor homogenizes the sample
by spinning the filter and creating shear forces that breaks up
any clumped material (blood, mucin, and nondiagnostic
material). The cells are then transferred onto a polycarbonate
filter membrane of the TransCyt filter and transferred onto a
glass slide to produce a circular monolayer of cells ∼20 mm
in diameter. The slide is then ejected into a fixative bath of
95% ethanol.
2.3 Raman Spectroscopy
All Raman analyses was performed using a HORIBA Jobin
Yvon XplorRA™ system (Villeneuve d’Ascq, France), which
incorporates an Olympus microscope BX41 equipped with
a ×100 objective (MPlan, Olympus, NA ¼ 0.9). A 532-nm
diode laser source was used. Laser power was set to 100%
resulting in 16 mW at the objective. The confocal hole coupled
to a slit aperture of 100 μm was set at 100 μm for all the mea-
surements. The system was precalibrated to the 520.7 cm−1
spectral line for silicon. About 1200 lines/grating mm were
used. The backscatter light was measured using an air-cooled
CCD detector (Andor, 1024 × 256 pixels). The spectrometer
was controlled by Labspec V5.0 software. Two accumulations
of 30 s were performed on each cell nucleus selected. Raman
spectra were acquired from the nuclei of randomly selected
morphologically normal superficial and intermediate cells from
each unstained pap smear.
Fig. 3 (a) Untreated pap smear, blood scale 3, stars indicate recorded nuclei in field-of-view.
Bar ¼ 35 μm. (b) Raman spectra recorded from untreated pap smear. (c) Treated pap smear, stars indi-
cate recorded nuclei in field-of-view. Bar ¼ 35 μm. (d) Raman spectra recorded from treated pap smear.
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2.4 Data Preprocessing and Analysis
Data were normalized and analyzed using MATLAB software
(Mathworks) and specific scripts developed and adapted for
uploading of the spectra and their preprocessing, including
smoothing (Savitzky–Golay K ¼ 5, K ¼ 13) baseline correc-
tion (rubberband) and vector normalization. The spectra were
also corrected for the glass background using a linear least-
squares method with non-negative constraints. The least-squares
model was developed using spectra from the ThinPrep glass
slides and selected pure biochemicals (e.g., actin, collagen,
RNA, DNA, etc.) that approximate the biochemical composition
of cervical cells. The data were mean centered and subjected to
partial least squares discriminant analysis (PLS-DA). PLS-DA
involves the creation of latent variables to maximize the cova-
riation between known datasets and the response variable which
they are regressed against. PLS-DA is a form of analysis that has
the ability to distinguish between known classifications of sam-
ples (negative, HG) and its aim is to find latent variables and
directions to maximize separation in a multivariate space. To
validate the method leave one patient out cross validation was
performed. This involves data from one patient sample being
removed from the model and the process is repeated until all
samples have been left out once.
3 Results
Figure 3(a) shows an untreated Pap smear, blood scale 3. The
slide was coated in blood and cellular debris. Figure 3(b) shows
Raman spectra recorded from cells present on the slide. Very
few cells were present and often burned on contact with the
laser. A high background was observed together with Raman
bands associated with blood at 754, 1311, 1374, 1398, 1588,
1640 cm−1. The high background can be attributed to the cel-
lular debris or a subunit of the oxidized hemoglobin on the
surface of the cell nuclei, which has a weak fluorescence.11
Figure 3(c) shows the same sample from Fig. 3(a) after under-
going the blood removal method. Any blood residue has been
oxidized with the H2O2 treatment and cellular debris has been
reduced allowing for high quality spectra to be recorded as
demonstrated in Fig. 3(d).
In order to determine if the Raman specific method of blood
removal usingH2O2 had any effect on the spectra recorded with-
out any external confounding factors, such as inflammation,
HPV infection, etc., the protocol was performed on HeLa cer-
vical cancer cells. HeLa cells were seeded with blood to mimic
cytology samples with blood scale index 2 and 3 and HeLa cells
with no added blood acted as controls. Both sample types
were treated with H2O2 and slides prepared as for the ThinPrep
Fig. 4 (a) Mean Raman spectra of HeLa cervical cancer cells treated with blood (blood scale 2 and 3)
and subsequently treated with H2O2 (red) and HeLa cervical cancer cells not treated with blood but
treated with H2O2 (blue), (b) mean Raman spectra of true negative samples (TN), blood scale 2 and
3, treated with H2O2 (red) and blood scale 0, treated with H2O2, (c) mean Raman spectra of HG samples,
blood scale 2 and 3 treated with H2O2 (red) and blood scale 0, treated with H2O2.
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cytology samples. Figure 4(a) shows the mean Raman spectra
recorded from 30 HeLa cells with and without blood contami-
nation (blood scale 2 and 3) and treated with H2O2. The mean
spectra display strong similarities with only minor changes at
1242 cm−1 (Amide III), 1350 cm−1 (DNA/RNA, CH def. in
proteins and carbohydrates), 1430 cm−1 (protein, lipids), and
1669 cm−1 (Amide I). Figure 4(b) shows the mean Raman spec-
tra of negative cytology samples (TN) with and without blood
contamination (blood scale 2 and 3) and treated with H2O2.
The mean spectra display strong similarities with small changes
at 1242, 1350, 1430, and 1669 cm−1 as observed for the
HeLa cells. These small changes in the spectra were consistent
throughout all samples tested including the HG samples
[Fig. 4(c)].
PLS-DA classification of negative cytology samples and HG
cytology samples, blood scale index 0, is shown in Fig. 5.
Figure 5(a) is a latent variables (LV) scores scatter plot of
LV1 and LV2, which shows good discrimination along LV1.
The loadings, as shown in Fig. 5(b), show that the discrimina-
tion is based around Raman peaks at 482, 851, 936, 1128, 1338,
1449, 1572, 1655, and 1669 cm−1, which are mainly related to
DNA, proteins, and glycogen. Figure 5(c) is a PLS-DA predic-
tion plot showing good classification of negative and HG sam-
ples with a sensitivity of 92% and a specificity of 93% (Table 1).
PLS-DA classification of TN and HG cytology samples,
blood scale index 2 and 3, is shown in Fig. 6. Both negative
and HG samples have undergone the Raman-specific blood
removal method. Figure 6(a) is a LV scores scatter plot of treated
TN and HG samples, which show overlap between the samples.
The LV1 loadings, as shown in Fig. 6(b), show that the discrimi-
nation is based around Raman peaks at 482, 549, 851, 936,
1145, 1182, 1237, 1338, 1449, 1576, and 1669 cm−1 and are
similar to the loadings shown in Fig. 5(b). The PLS-DA predic-
tion plot is shown in Fig. 6(c) and has a sensitivity of 89% and
a specificity of 88% (Table 1).
In order to determine if excessively bloody samples could be
treated the same way as nonbloody samples in terms of data
analysis, the Raman spectral data from the two groups (blood
scale 0 and blood scale 2 and 3) were combined. Figure 7(a)
shows the LV scores scatter plot, which highlights decreased
discrimination between TN and HG cytology. However, the
loadings shown in Fig. 7(b) remain similar to the loadings
shown in Figs. 5(b) and 6(b) with Raman peaks at 482, 851,
1129, 1184, 1251, 1338, 1449, and 1669 cm−1. The PLS-DA
prediction plot is shown in Fig. 7(c) and has a sensitivity of
82% and a specificity of 87% (Table 1).
Interestingly, the loadings (482, 851, 936, 1149, 1338 and
1669 cm−1) remain almost the same between all three datasets,
blood scale 0, blood scale 2 and 3 and combined, confirming
that glycogen, DNA, and proteins are the main discriminating
features between negative cytology and HG cytology samples
regardless of blood contamination. Similar findings have
Fig. 5 (a) LV score scatter plot of Raman spectra acquired from 15 TN samples and 15 HG samples
(blood scale index 0), (b) LV 1 loadings, and (c) PLS-DA prediction plot showing good discrimination
between TN (blue) and HG (red) ThinPrep cytology samples.
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been reported previously.17,19 However, as mentioned earlier,
some spectral features undergo minor changes following the
blood removal method. As these features overlap with the dis-
criminating features, this results in a reduction in classification
efficiency when excessively bloody (blood scale index 2 and 3)
samples and nonbloody samples (blood scale index 0) samples
are combined for analysis. Comparing sensitivity and specificity
of the test groups shows that blood scale 0 samples with no
blood contamination performed best with a sensitivity of 92%
and specificity of 93% when compared to excessively bloody
blood scale 2 and 3 samples, which had a sensitivity of 89%
and specificity of 88%. Combining the blood scale 0 and
blood scale 2 and 3 samples for analysis resulted in a sensitivity
of 82% and specificity of 87%. The high specificity indicates
a good ability to accurately exclude negative samples (few
false positives), however, the reduction in sensitivity indicates
a reduced ability to accurately detect HG samples and an
increased likelihood of false negatives.
Despite the reduction in classification efficiency, the values
are higher than previously reported for samples with blood con-
tamination. Rubina et al.16 reported a classification efficiency of
78% and 79% for normal and abnormal bloody samples treated
with red blood cell lysis buffer. In addition, Kerr et al.20 con-
cluded that excessively bloody samples were not suitable for
diagnostics with Raman spectroscopy.
4 Conclusion
This study demonstrates for the first time that excessively
bloody (blood scale 2 and 3) ThinPrep cervical smear samples
can be used for diagnostics with Raman spectroscopy following
a hydrogen peroxide treatment in the collection vial. However,
the presence of excessive blood contamination (blood scale
index 2 and 3) did result in reduced sensitivity and specificity
for classification of negative and HG samples. A higher sensi-
tivity and specificity could be achieved by keeping excessively
bloody samples separate from nonbloody samples for analysis.
Although this study has focused only on cervical cytology sam-
ples, thyroid, urine, and serous fluid cytology samples may also
Table 1 Sensitivity and specificity from PLS-DA classification of TN
and HG cervical cytology samples with and without blood contamina-
tion and combined.
Sensitivity (%) Specificity (%)
Negative versus HG
(blood scale 0)
92 93
Negative versus HG
(blood scale 2 and 3)
89 88
Combined (blood scale 0
and 2 and 3)
82 87
Fig. 6 (a) LV score scatter plot of Raman spectra acquired from 15 TN and 15 HG samples (blood scale
index 2 and 3), (b) LV1 loadings, (c) PLS-DA prediction plot showing some discrimination between TN
(blue) and HG (red) ThinPrep cytology samples, blood scale 2 and 3 and treated with H2O2.
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benefit from such an approach for Raman spectroscopic analy-
sis. Serous fluids for cytological examination are often contami-
nated with a high level of blood (pericardium, pleura, and
peritoneum fluids) and often require additional treatment meth-
ods, such a density gradient technique to remove red blood cells,
which can result in a loss of diagnostic cellular material. The
application of our blood treatment method would prevent this
loss of material and allow Raman spectroscopy to be performed.
While these results are promising for the development of
Raman spectroscopy for cervical cancer screening, Raman
spectroscopy in its current form does not have the ability to
replace cytology for cervical cancer screening and its associated
benefits (e.g., detection of Herpes Simplex virus or actinomyces
like organisms). However, it could be used to supplement the
pap test or it could have potential as a triage test after HPV
testing.
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